How Sarepta Therapeutics makes money

Period

FY2025

How does Sarepta Therapeutics make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Sarepta Therapeutics Inc. Common Stock (DE) · FY2025 · year ended 2025-12-31

Revenue$2.2BNet loss$711M · 32%Cost of revenue$26M · 1%Gross profit$2.2B · 99%Operating expenses$2.9B · 131%R&D$1.5B · 69%SG&A$492M · 22%Other opex$859M · 39%Income tax$11M · 1%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.